drugset / Trial / NCT02668146

An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor

NCT02668146

Phase 2 Unknown 16 enrolled VA Greater Los Angeles Healthcare System
RandomizedCrossoverOpen-labelTreatment

Summary

Obtain information on whether the medication Perampanel reduces tremor in people with essential tremor and is well-tolerated.

Timeline

Start
2015-10
Primary completion
2017-03
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Perampanel Small molecule

Indications